Bechini Angela, Cosma Claudia, Di Pisa Giulia, Fanfani Alice, Ionita Giulia, Liedl Davide, Lunetta Carla, Martorella Linda, Mele Silvia, Stacchini Lorenzo, Vaccaro Gabriele, Zuccaro Ornella, Valente Stefano, Prandi Gian Marco, Bonanni Paolo, Boccalini Sara
Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Medical Specialization School of Hygiene and Preventive Medicine, University of Florence, 50134 Florence, Italy.
Vaccines (Basel). 2024 May 7;12(5):504. doi: 10.3390/vaccines12050504.
Human Papilloma Virus (HPV) infection and HPV-related cancers can be prevented through vaccinations and mass cervical screening programmes. The Ministry of Health in Italy provides recommendations on primary and secondary prevention of HPV-related diseases, but the 19 Italian regions and 2 autonomous provinces have organisational and decision-making autonomy, with differences in the strategies for offering prevention. The aim of this study is to describe the HPV vaccination and cervical screening offered in all Italian regions. Regional official documents up until 31 December 2021 were first identified. Subsequently, primary and secondary prevention experts from each region were interviewed to validate the previously collected data. The National Immunisation Plan (NIP) 2017-2019 recommends HPV vaccination from the age of 11 for both sexes, with a coverage target of 95%. HPV vaccination is offered free of charge or co-payment. All regions have screening programmes for cervical cancer, using PAP or HPV-DNA tests every three to five years. All regions have an electronic registry for vaccination and screening status. All regions have developed awareness-raising campaigns. It is important to harmonise regional policies with the implementation of information systems integration. The collected data could enhance both regional and national public health initiatives, bolstering the resilience of vaccination programs.
人乳头瘤病毒（HPV）感染及HPV相关癌症可通过疫苗接种和大规模宫颈癌筛查计划来预防。意大利卫生部就HPV相关疾病的一级和二级预防提供建议，但意大利的19个大区和2个自治省拥有组织和决策自主权，在提供预防措施的策略上存在差异。本研究的目的是描述意大利所有大区提供的HPV疫苗接种和宫颈癌筛查情况。首先确定截至2021年12月31日的各地区官方文件。随后，对每个地区的一级和二级预防专家进行访谈，以验证先前收集的数据。2017 - 2019年国家免疫计划（NIP）建议男女均从11岁开始接种HPV疫苗，覆盖率目标为95%。HPV疫苗接种免费或需自付部分费用。所有大区都有宫颈癌筛查计划，每三到五年使用巴氏涂片或HPV-DNA检测。所有大区都有疫苗接种和筛查状况的电子登记系统。所有大区都开展了提高认识的活动。将地区政策与信息系统整合的实施相协调很重要。所收集的数据可加强地区和国家的公共卫生举措，增强疫苗接种计划的韧性。
